ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ELUT Elutia Inc

3,31
0,09 (2,80%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:30:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Elutia Inc ELUT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,09 2,80% 3,31 22:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,34 3,24 3,42 3,31 3,22
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
13.5.202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.5.202414:00GLOBEElutia to Showcase BioEnvelope Product Line at Heart Rhythm..
09.5.202423:26EDGAR2Form 8-K - Current report
09.5.202422:05GLOBEElutia Announces First Quarter 2024 Results: SimpliDerm®..
02.5.202422:05GLOBEElutia to Report First Quarter 2024 Financial Results on..
24.4.202422:05GLOBEElutia to Present at the Planet MicroCap Showcase: VEGAS..
11.3.202414:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07.3.202422:24EDGAR2Form 8-K - Current report
07.3.202422:05GLOBEElutia Reports Fourth Quarter and Full Year 2023 Financial..
22.2.202422:05GLOBEElutia to Report Fourth Quarter and Full Year 2023 Financial..
14.2.202422:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02.2.202422:30EDGAR2Form 8-K - Current report
25.1.202422:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
12.1.202423:00EDGAR2Form 8-K - Current report
10.1.202423:00EDGAR2Form 8-K - Current report
10.1.202422:05GLOBEElutia Regains Compliance with Nasdaq Listing Requirements
09.1.202422:17EDGAR2Form SC 13D/A - General statement of acquisition of..
08.1.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202322:30EDGAR2Form 8-K - Current report
18.12.202314:00GLOBEElutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for..
08.12.202322:04EDGAR2Form 8-K - Current report
05.12.202322:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05.12.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
20.11.202322:53EDGAR2Form S-3 - Registration statement under Securities Act of..
20.11.202322:02EDGAR2Form 8-K - Current report
15.11.202323:26EDGAR2Form 8-K - Current report
13.11.202322:05GLOBEElutia Reports 26% Year-Over-Year Sales Growth of..
09.11.202315:19EDGAR2Form 8-K - Current report
09.11.202314:30GLOBEElutia Completes Divestiture of Orthobiologics Business Unit..
07.11.202322:04EDGAR2Form 8-K - Current report
06.11.202322:05GLOBEElutia to Report Third Quarter 2023 Financial Results on..
18.10.202314:00PRNUSSWK Holdings Highlights Recent Achievements and Provides..
06.10.202321:28EDGAR2Form SC 13D/A - General statement of acquisition of..
05.10.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202322:05EDGAR2Form 8-K - Current report
20.9.202314:30GLOBEElutia to Participate in a Panel Discussion at the Cantor..
19.9.202314:36GLOBEElutia Announces Private Placement for Proceeds Up to $26..
19.9.202314:30EDGAR2Form 8-K - Current report
18.9.202322:08GLOBEElutia Announces Sale of Orthobiologics Business Unit for..
08.9.202314:30GLOBEElutia to Present at the H.C. Wainwright 25th Annual Global..
06.9.202322:05GLOBEAziyo Biologics Rebrands as Elutia to Reflect Strategic..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock